Photonic Integrated Circuit Market Size, Share & Trends Analysis Report By Material (III-V Material, Lithium Niobate, Silica-on-silicon), By Integration Process (Hybrid), By Application, By Region, And Segment Forecasts, 2025 - 2030

Photonic Integrated Circuit Market Size, Share & Trends Analysis Report By Material (III-V Material, Lithium Niobate, Silica-on-silicon), By Integration Process (Hybrid), By Application, By Region, And Segment Forecasts, 2025 - 2030


Photonic Integrated Circuit Market Growth & Trends

The global photonic integrated circuit market size is expected to reach USD 25.80 billion by 2030, registering a CAGR of 10.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Photonic IC is an integrated circuit that uses optical wavelength as an information signal and provides multiple integrated photonic functions. Photonic IC, as such, is similar to an electronic IC and can be a viable replacement for it as well as for the copper-based wired transmission. Photonic IC forms an integral part of lasers, optical amplifiers, modulators, and MUX/DEMUX components, which are extensively used in the optical signal processing, optical communication, biophotonics, and sensing applications. The growing demand for sensing and optical devices are expected to fuel the growth of the photonic IC market.

There is an increasing need for cost effective, power efficient, and compact PICs which would further propel the photonic IC market over the forecast period across the mobile broadband Internet access, high-performance computing, datacenter, and enterprise networking, along with metro and long haul data communications, among many others. The increasing adoption of the high-level integrated PICs and application-specific PICs would boost the photonic IC market to strive for greater functionality and new product development across a number of verticals.

The photonic IC market is anticipated to grow substantially due to the continuous technological advancements and the evolving end-user demands. The laser, optical amplifier, and MUX/DEMUX component segments possess enormous growing opportunities, owing to the ability of photonic ICs to incorporate new optical functionalities that can be embedded on a single chip to achieve high efficiency and compactness.

The increasing demand for the optical communication and sensing applications is driving the growth of photonic ICs around the globe with an efficient management of datacenters and long haul networks providing a thriving market for them. Moreover, with the advancements in quantum computing, the adoption of photonic ICs are increasing as they allow multitasking that quantum computing readily requires. Also, the growing adoption of the biophotonic application in medical devices also holds considerable growth opportunities for the photonic ICs market. On the other hand, the high bandwidth and optimum performance requirements of the telecommunication industry, data storage, cloud service providers, and large business enterprises are expected to boost the optical communication and signal processing segments. This market will create many new opportunities culminating in an increased adoption of photonic ICs over the forecasted period.

Photonic Integrated Circuit Market Report Highlights
  • Based on materials, the III-V Material segment dominated the global photonic integrated circuit market industry with a revenue share of 33.2% in 2024.
  • Based on integration process, the hybrid integration segment dominated the global market for photonic integrated circuits in 2024. Some of the common techniques for hybrid integration include selective area growth, die-to-wafer bonding, flip-chip bonding, and others.
  • Based on application, the data centers segment accounted for the largest revenue share of the global market in 2024. This is attributed to the performance improvement capacities of photonic integrated circuits (PICs).
  • North America photonic integrated circuit market held the largest revenue share of 38.5% in 2024. This is attributed to factors such as growing 5G networks in the region, the large number of data centers operating in North America, the growing demand for the biomedical sector, and the presence of multiple semiconductor market participants in the region.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Veterinary Antibiotics Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising focus on animal-only antibiotics and ionophores
3.2.1.2. Growing Initiatives by key companies And launch of new products
3.2.1.3. Increasing Incidence of Livestock Diseases
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulations
3.2.2.2. Decline In the use of antibiotics
3.2.2.3. Rising research on antibiotic alternatives
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Veterinary Antibiotics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental Landscape
3.3.3. Regulatory Framework
3.3.4. Patent-Off Dates Analysis for Major Veterinary Antibiotics
3.3.5. Product Pipeline Analysis
3.3.6. Overall Estimated Sales Of Antimicrobial VMPs (Active Substance) In Tonnes By European Country, 2023
3.3.7. Estimated Sales Of Antimicrobial Active Substances in Production Animals in Europe, By Antimicrobial Class, 2023
3.3.8. COVID-19 Impact Analysis
Chapter 4. Veterinary Antibiotics Market: Animal Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Veterinary Antibiotics Market: Animal Type Movement Analysis
4.3. Veterinary Antibiotics Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
4.4. Cattle
4.4.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Pigs
4.5.1. Pigs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Sheep & Goat
4.6.1. Sheep & Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Poultry
4.7.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Veterinary Antibiotics Market: Drug Class Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Veterinary Antibiotics Market: By Drug Class Movement Analysis
5.3. Veterinary Antibiotics Market Size & Trend Analysis, by drug class, 2018 to 2030 (USD Million)
5.3.1. Tetracyclines
5.3.1.1. Tetracyclines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Penicillins
5.3.2.1. Penicillins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Sulfonamides
5.3.3.1. Sulfonamides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. Penicillins
5.3.4.1. Penicillins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Macrolides
5.3.5.1. Macrolides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. Trimethoprim
5.3.6.1. Trimethoprim Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. Lincosamides
5.3.7.1. Lincosamides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.8. Polymyxins
5.3.8.1. Polymyxins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.9. Aminoglycosides
5.3.9.1. Aminoglycosides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.10. Fluoroquinolones
5.3.10.1. Fluoroquinolones Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.11. Pleuromutilins
5.3.11.1. Pleuromutilins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.12. Others
5.3.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Veterinary Antibiotics Market: Dosage Form Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Veterinary Antibiotics Market: By Dosage Form Movement Analysis
6.3. Veterinary Antibiotics Market Size & Trend Analysis, by dosage form, 2018 to 2030 (USD Million)
6.3.1. Oral Powders
6.3.1.1. Oral Powders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. Oral solutions
6.3.2.1. Oral Solutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Injections
6.3.3.1. Injections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. Others
6.3.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Veterinary Antibiotics Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Veterinary Antibiotics Market Share, By Region, 2024 & 2030, USD Million
7.3. Regional Outlook
7.4. North America
7.4.1. North America Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. U.S. Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Canada Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. UK Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Germany Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. France Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Italy Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Spain Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Denmark Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Sweden Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Norway Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.10. Belgium
7.5.10.1. Key Country Dynamics
7.5.10.2. Belgium Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.11. Hungary
7.5.11.1. Key Country Dynamics
7.5.11.2. Hungary Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.12. Poland
7.5.12.1. Key Country Dynamics
7.5.12.2. Poland Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.13. Portugal
7.5.13.1. Key Country Dynamics
7.5.13.2. Portugal Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.14. Romania
7.5.14.1. Key Country Dynamics
7.5.14.2. Romania Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.15. Netherlands
7.5.15.1. Key Country Dynamics
7.5.15.2. Romania Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Japan Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. China Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. India Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Australia Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. South Korea Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Brazil Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.7.3. Mexico
7.7.3.1. Key Country Dynamics
7.7.3.2. Mexico Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.7.4. Argentina
7.7.4.1. Key Country Dynamics
7.7.4.2. Argentina Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. South Africa Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Saudi Arabia Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. UAE Veterinary Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heap Map Analysis
8.3. Company Profiles
8.3.1. Merck & Co., Inc.
8.3.1.1. Participant’s Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Ceva Santé Animale.
8.3.2.1. Participant’s Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Vetoquinol
8.3.3.1. Participant’s Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Zoetis Services LLC
8.3.4.1. Participant’s Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Boehringer Ingelheim International GmbH
8.3.5.1. Participant’s Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Dechra Pharmaceuticals PLC
8.3.6.1. Participant’s Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Elanco Animal Health Incorporated
8.3.7.1. Participant’s Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Virbac S.A.
8.3.8.1. Participant’s Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Calier.
8.3.9.1. Participant’s Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Bimeda, Inc
8.3.10.1. Participant’s Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Prodivet Pharmaceuticals SA/NV
8.3.11.1. Participant’s Overview
8.3.11.2. Financial Performance
8.3.11.3. Product Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Norbrook Laboratories
8.3.12.1. Participant’s Overview
8.3.12.2. Financial Performance
8.3.12.3. Product Benchmarking
8.3.12.4. Strategic Initiatives
8.4. Strategy Mapping
8.4.1. Mergers & Acquisitions
8.4.2. Partnerships & Collaborations
8.4.3. Expansion
8.4.4. Product launch
8.4.5. Product Approval
8.4.6. Others
8.5. List of Other Players

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings